Rare Disease Research & Support
Rare Diseases are diseases that affect less than 200,000 people in the United States. While the occurrence of any individual rare disease can be low, the needs and experiences of the people affected by rare diseases are significant and important. We seek to recognize and advance our understanding of the rare diseases that impact people in the Michigan community as well as support the individuals affected by those rare diseases.
At Calvin University, our goal is to advance research in the area of mitochondrial rare diseases, in particular exploring the ways that collaborative research can increase advances in and dissemination of rare disease research. We also aim to directly serve the needs of the Michigan rare disease community and equip students to engage in rare disease research and community support efforts.
Find out more about ways you can participate in this research as a student.
There are more Americans who live with a rare disease than ALL of those who have been diagnosed with HIV, heart disease, or stroke. Find out more about research happening at Calvin University and in the state of Michigan.
- 95% of rare disease do not have an FDA approved treatment or therapy.
- Rare diseases with FDA approved treatments still have high costs and variability, limiting their accessibility.
- Approximately 50% of the people affected by rare diseases are children, and 30% of those children will not live to see their 5th birthday.
- Rare diseases also offer an opportunity to better understand how our bodies function, which better enables us to understand and combat diseases that are designated as common diseases, including cardiovascular disease (56,888,289 deaths in 2008), infectious and parasitic diseases (8,721,166 deaths in 2008), diabetes (1,255,585 deaths in 2008), and Alzheimer’s and other dementias (539,948 deaths in 2008).1
Rare disease research at Calvin
At Calvin, our research focuses on rare diseases that cause mitochondrial dysfunction. By studying mitochondrial rare diseases, we hope to advance understanding of particular rare diseases as well as increase our understanding of mitochondrial function and its role in common diseases. Our goal is to develop model systems and assays that will allow us to differentiate the effects of various mutations so that we can understand and predict the severity of novel mutations. Read more about our current projects..
Rare disease research updates
1 National Organization for Rare Disorders Fact Sheet, NORD, 2016
- Course code: